43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 13
17:20 UTC
|
CAH
Cardinal Health
|
◎ Target | Charles Rhyee ★★★☆☆ #1267 | Buy | $275.00→ $280.00+1.8% |
|
Aug 13
17:20 UTC
|
ATO
Atmos Energy
|
◎ Target | Richard Sunderland ★★★☆☆ #1537 | Hold | $188.00→ $179.00-4.8% |
|
Aug 13
16:20 UTC
|
WPRT
Westport Fuel Systems
|
◎ Target | Christopher Dendrinos not yet tracked | Sec→ r Perform | $1.75→ $1.00-42.9% |
|
Aug 13
16:20 UTC
|
WPC
W.P. Carey
|
◎ Target | Nicholas Yulico ★★★☆☆ #1398 | Sec→ r Perform | $76.00→ $77.00+1.3% |
|
Aug 13
16:20 UTC
|
VSTS
Vestis
|
◎ Target | Andrew Steinerman ★★★★☆ #772 | Underweight | $11.00→ $13.00+18.2% |
|
Aug 13
16:20 UTC
|
TRMB
Trimble
|
◎ Target | Tami Zakaria ★★★☆☆ #1852 | Overweight | $75.00→ $76.00+1.3% |
|
Aug 13
16:20 UTC
|
STUB
STUB
|
◎ Target | Jed Kelly ★★★☆☆ #1544 | Outperform | $12.00→ $11.00-8.3% |
|
Aug 13
16:20 UTC
|
SRRK
Scholar Rock
|
◎ Target | Tessa Romero ★★★☆☆ #1178 | Overweight | $56.00→ $63.00+12.5% |
|
Aug 13
16:20 UTC
|
PHVS
Pharvaris
|
◎ Target | Brian Abrahams ★★☆☆☆ #2623 | Outperform | $51.00→ $52.00+2.0% |
|
Aug 13
16:20 UTC
|
PGNY
Progyny
|
◎ Target | Jailendra Singh ★★★☆☆ #1490 | Buy | $33.00→ $36.00+9.1% |
|
Aug 13
16:20 UTC
|
OLMA
Olema Pharmaceuticals
|
◎ Target | Anupam Rama ★★★☆☆ #1754 | Overweight | $52.00→ $46.00-11.5% |
|
Aug 13
16:20 UTC
|
NEXN
Nexxen International
|
◎ Target | Matthew Swanson ★★☆☆☆ #2438 | Outperform | $11.00→ $13.00+18.2% |
|
Aug 13
16:20 UTC
|
MYRG
MYR Group
|
◎ Target | Ati Modak not yet tracked | Neutral | $469.00→ $422.00-10.0% |
|
Aug 13
16:20 UTC
|
MSGE
Madison Square Garden Entertainment
|
◎ Target | David Karnovsky ★★★★☆ #802 | Neutral | $75.00→ $83.00+10.7% |
|
Aug 13
16:20 UTC
|
KGS
Kodiak Gas Services
|
◎ Target | Elvira Scotto ★★★☆☆ #2192 | Outperform | $84.00→ $88.00+4.8% |
|
Aug 13
16:20 UTC
|
KBDC
Kayne Anderson BDC
|
◎ Target | Kenneth S. Lee not yet tracked | Outperform | $16.00→ $15.00-6.2% |
|
Aug 13
16:20 UTC
|
JMIA
Jumia Technologies
|
◎ Target | Brad Erickson ★★☆☆☆ #2628 | Outperform | $15.00→ $13.00-13.3% |
|
Aug 13
16:20 UTC
|
JACK
Jack In The Box
|
◎ Target | Logan Reich ★★☆☆☆ #2472 | Outperform | $16.00→ $22.00+37.5% |
|
Aug 13
16:20 UTC
|
JACK
Jack In The Box
|
◎ Target | Nick Setyan ★★★☆☆ #1592 | Neutral | $13.00→ $16.00+23.1% |
|
Aug 13
16:20 UTC
|
GLPI
Gaming and Leisure Properties
|
◎ Target | Greg McGinniss ★★★☆☆ #1431 | Sec→ r Perform | $49.00→ $50.00+2.0% |
|
Aug 13
16:20 UTC
|
DOCS
Doximity
|
◎ Target | Jailendra Singh ★★★☆☆ #1490 | Hold | $19.00→ $24.00+26.3% |
|
Aug 13
16:20 UTC
|
DFTX
Definium Therapeutics
|
◎ Target | Brian Abrahams ★★☆☆☆ #2623 | Outperform | $57.00→ $66.00+15.8% |
|
Aug 13
16:20 UTC
|
CYTK
Cytokinetics
|
◎ Target | Tessa Romero ★★★☆☆ #1178 | Overweight | $97.00→ $103.00+6.2% |
|
Aug 13
16:20 UTC
|
CTMX
CytomX Therapeutics
|
◎ Target | Anupam Rama ★★★☆☆ #1754 | Overweight | $12.00→ $11.00-8.3% |
|
Aug 13
16:20 UTC
|
CSCO
Cisco Systems
|
◎ Target | Matthew Niknam ★★★☆☆ #1840 | Buy | $125.00→ $140.00+12.0% |
|
Aug 13
16:20 UTC
|
CPT
Camden Property Trust
|
◎ Target | Anthony Paolone ★★★★☆ #952 | Neutral | $113.00→ $114.00+0.9% |
|
Aug 13
16:20 UTC
|
COLD
Americold Realty Trust
|
◎ Target | Greg McGinniss ★★★☆☆ #1431 | Sec→ r Perform | $15.00→ $16.00+6.7% |
|
Aug 13
16:20 UTC
|
CIB
Grupo Cibest
|
◎ Target | Tito Labarta ★★★☆☆ #1020 | Buy | $98.00→ $110.00+12.2% |
|
Aug 13
16:20 UTC
|
CCOI
Cogent Communications
|
◎ Target | Jonathan Atkin ★★★☆☆ #1587 | Sec→ r Perform | $18.00→ $12.00-33.3% |
|
Aug 13
16:20 UTC
|
CC
Chemours
|
◎ Target | Jeffrey Zekauskas ★★★★☆ #500 | Neutral | $22.00→ $15.00-31.8% |
|
Aug 13
16:20 UTC
|
CAH
Cardinal Health
|
◎ Target | Lisa Gill ★★★★☆ #593 | Neutral | $215.00→ $260.00+20.9% |
|
Aug 13
16:20 UTC
|
ATEX
Anterix
|
◎ Target | Sebastiano Petti ★★★☆☆ #1875 | Overweight | $133.00→ $130.00-2.3% |
|
Aug 13
16:20 UTC
|
APGE
Apogee Therapeutics
|
◎ Target | Danielle Brill ★★☆☆☆ #2280 | Hold | $81.00→ $135.00+66.7% |
|
Aug 13
15:19 UTC
|
WULF
TeraWulf
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3235 | Overweight | $72.00→ $62.50-13.2% |
|
Aug 13
15:19 UTC
|
TRAX
First Tracks Biotherapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #2240 | Overweight | $48.00→ $65.00+35.4% |
|
Aug 13
15:19 UTC
|
TDY
Teledyne Technologies
|
◎ Target | Kristine Liwag ★★★☆☆ #1885 | Equal Weight | $680.00→ $715.00+5.1% |
|
Aug 13
15:19 UTC
|
TDW
Tidewater
|
◎ Target | Eddie Kim ★★★☆☆ #2109 | Equal Weight | $86.00→ $91.00+5.8% |
|
Aug 13
15:19 UTC
|
STUB
STUB
|
◎ Target | Curry Baker ★★★☆☆ #1025 | Buy | $12.50→ $11.00-12.0% |
|
Aug 13
15:19 UTC
|
SPT
Sprout Social
|
◎ Target | Elizabeth Porter ★★★☆☆ #1012 | Equal Weight | $10.00→ $11.00+10.0% |
|
Aug 13
15:19 UTC
|
SMWB
Similarweb
|
◎ Target | Raimo Lenschow ★★★☆☆ #1626 | Overweight | $5.00→ $11.00+120.0% |
|
Aug 13
15:19 UTC
|
PLGO
Fidelis Insurance
|
◎ Target | Alex Scott ★★★☆☆ #1835 | Equal Weight | $24.00→ $23.00-4.2% |
|
Aug 13
15:19 UTC
|
PHVS
Pharvaris
|
◎ Target | Debjit Chattopadhyay ★★★☆☆ #1736 | Buy | $39.00→ $40.00+2.6% |
|
Aug 13
15:19 UTC
|
P
Everpure
|
◎ Target | Howard Ma ★★★★☆ #875 | Buy | $115.00→ $150.00+30.4% |
|
Aug 13
15:19 UTC
|
NBIX
Neurocrine Biosciences
|
◎ Target | Jeffrey Hung not yet tracked | Equal Weight | $196.00→ $182.00-7.1% |
|
Aug 13
15:19 UTC
|
MRX
Marex Group plc Ordinary Shares
|
◎ Target | Benjamin Budish ★★☆☆☆ #2437 | Overweight | $76.00→ $86.00+13.2% |
|
Aug 13
15:19 UTC
|
MLM
Martin Marietta Materials
|
◎ Target | Angel Castillo ★★☆☆☆ #2346 | Overweight | $664.00→ $639.00-3.8% |
|
Aug 13
15:19 UTC
|
MDB
MongoDB
|
◎ Target | Rishi Jaluria ★★☆☆☆ #2391 | Outperform | $395.00→ $515.00+30.4% |
|
Aug 13
15:19 UTC
|
MARA
Marathon Digital
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3235 | Underweight | $5.50→ $6.00+9.1% |
|
Aug 13
15:19 UTC
|
KTB
Kontoor Brands
|
◎ Target | Adrienne Yih ★★★☆☆ #1659 | Overweight | $96.00→ $99.00+3.1% |
|
Aug 13
15:19 UTC
|
KRNT
Kornit Digital
|
◎ Target | Erik Woodring ★★☆☆☆ #2547 | Equal Weight | $18.00→ $19.00+5.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.